THE USE OF SUCCINATES FOR THE CORRECTION OF METABOLIC DISORDERS IN THE PENUMBRA IN PATIENTS WITH STROKE

Abstract


The aim of the study was to determine the quantitative content and correlation between metabolites in the core ischemic zone, the ischemic penumbra and the intact tissue of the opposite hemisphere in the acute stage of ischemic stroke using MR-spectroscopy. We studied 72 patients, including 37 patients (the main group) treated with the antioxidant mexidol (2-ethyl-6-methyl-3-hydroxypiridine succinate) in addition to standard therapy and 35 patients who received standard therapy only. The severity of stroke was assessed using the NIHSS. The Barthel index and Rankin scale were used to evaluate functional outcome in the 30th day, hydrogen MR-spectroscopy was used twice: in the first 24 h from disease onset and in the 5th day. Mexidol used in dose 500 mg intravenously during 14 days reduced significantly the content of lactate (p=0.002) and inositol (p=0.005) in the cells compared to the control group that enhanced the restoration of the balance between aerobic and anaerobic mechanisms of oxidation and positively influenced on the rehabilitation of patients. Positive correlations between the content of lactate in the ischemic penumbra and NIHSS scores (r=0.5786; p=0.049) and the negative correlation between the content of lactate in the ischemic penumbra and the degree of functional restoration assessed by the Barthel index (r= -0.6305; p=0.028) were found. These findings support the evidence for the interaction between the disturbance of glucose metabolism in conditions of hypoxia and the degree of nervous tissue damage.

About the authors

Miroslav M Odinak

Kirov Military Medical Academy

194044, St. Petersburg, Academician Lebedev Street 6
department of nervous diseases

Staniskav N Yanishevskii

Kirov Military Medical Academy

Email: stasya71@yandex.ru
194044, St. Petersburg, Academician Lebedev Street 6
department of nervous diseases

Nikolay V Tsygan

Kirov Military Medical Academy

194044, St. Petersburg, Academician Lebedev Street 6
department of nervous diseases

Sergei Yu Golokhvastov

Kirov Military Medical Academy

194044, St. Petersburg, Academician Lebedev Street 6
department of nervous diseases

Igor A Vozniuk

Kirov Military Medical Academy

194044, St. Petersburg, Academician Lebedev Street 6
department of nervous diseases

Artem G Trufanov

Kirov Military Medical Academy

194044, St. Petersburg, Academician Lebedev Street 6
department of nervous diseases

References

  1. Ижбульдина Г.И. Изменения системы гемостаза и свободнорадикального окисления липидов в остром периоде ишемического инсульта на фоне нейропротективной терапии // Журн. неврол. и психиат. 2012. Т. 112, №3, вып. 2. С. 31-37.
  2. Подопригора А.Е., Пронин И.Н., Фадеева Л.М. Протонная магнитно-резонансная спектроскопия в нейрорентгенологии // Мед визуализация. 2000. 4. С. 86-91.
  3. Поздняков А.В. Роль протонной магнитно-резонансной спектроскопии в диагностике заболеваний головного мозга: Автореф. дисс.. д-ра мед. наук. СПб, 2001.
  4. Скворцова В.И., Стаховская Л.В., Нарциссов Я.Р. и др. Рандомизированное двойное слепое плацебо-контролируемое исследование эффективности и безопасности мексидола в комплексной терапии ишемического инсульта в остром периоде // Инсульт. 2006. № 18. С. 47-54.
  5. Чефранова Ж.Ю., Макортова Т.А., Удачин В.А., Колединцева Е.В. Оценка эффективности применения мексидола в сочетании с тромболитической терапией у больных с ишемическим инсультом // Журн. неврол. и психиат. 2012. Т. 112, № 4. С. 49-52.
  6. Bendszus M. et al. Sequential MR Imaging and Proton MR Spectroscopy in Patients Who Underwent Recent Detoxification for Chronic Alcoholism: Correlation with Clinical and Neuropsychological Data // Am. J. Neuroradiol. 2001. Vol. 22, № 10. P. 1926-1932.
  7. Coon A.L. et al. Correlation of cerebral metabolites with functional outcome in experimental primate stroke using in vivo 1H-magnetic resonance spectroscopy // Am. J. Neuroradiol. 2006. Vol. 27. № 5. P. 1053-1058.
  8. Kado H., Kimura H., Murata T. et al. Depressive Psychosis: Clinical Usefulness of MR Spectroscopy Data in Predicting Prognosis // Radiology. 2006. Vol. 238, № 1. P. 248-255.
  9. Kang D.W., Roh J.K., Lee Y.S. et al. Neuronal metabolic changes in the cortical region after subcortical infarction: a proton MR spectroscopy study // J. Neurol. Neurosurg. Psychiatry. 2000. Vol. 69, № 2. P. 222--227.
  10. Nicoli F., Lefur Y., Denis B. et al. Metabolic counterpart of decreased apparent diffusion coefficient during hyperacute ischemic stroke: a brain proton magnetic resonance spectroscopic imaging study // Stroke. 2003. Vol. 34. P. 82-87.
  11. Pereira А.С, Saunders D.E., Doyle V.L. Measurement of Initial N-Acetyl Aspartate Concentration by Magnetic Resonance Spectroscopy and Initial Infarct Volume by MRI Predicts Outcome in Patients With Middle Cerebral Artery Territory Infarction // Stroke. 1999. Vol. 30, № 8. P. 1577-1582.

Statistics

Views

Abstract - 54

Cited-By


Article Metrics

Metrics Loading ...

PlumX

Dimensions

Refbacks

  • There are currently no refbacks.

Copyright (c) 2014 Odinak M.M., Yanishevskii S.N., Tsygan N.V., Golokhvastov S.Y., Vozniuk I.A., Trufanov A.G.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies